The management of blood pressure in acute stroke

Lancet Neurology

Volumn 2, Issue 10, 2003, Pages 593-

  Chalmers, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

BLOOD PRESSURE MONITORING; BRAIN HEMORRHAGE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; PERFUSION; PRIORITY JOURNAL; RANDOMIZATION; SHORT SURVEY; STROKE;

EID: 0141626531     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00525-8     Document Type: Letter

References (5)

1. Bath P., Chalmers J., Powers W., et al. Statement on the management of blood pressure in acute stroke. J Hypertens. 21:2003;665-672.
2. Chalmers J., Todd A., Chapman N., et al. Statement on blood pressure lowering and stroke prevention. J Hypertens. 21:2003;651-663.
3. Chobanian A.V., Bakris G.L., Black H.L., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA. 289:2003;2560-2571.
4. Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 patients with previous stroke or transient ischaemic attack. Lancet. 358:2001;1033-1041.
5. Schrader J., Lüders S., Kulschewski A., et al. The ACCESS Study: Evaluation of acute condensation cilexetil therapy in stroke survivors. Stroke. 34:2003;1699-1703.